Examiner Boeckelman Jacob A

1655-BOECKELMAN-JACOB-A

Employment Information

Art Unit:1655 — Drug, bio-affecting and body treating compositions
Group:1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts
Classes: 424 — Drug, bio-affecting and body treating compositions
426 — Food or edible material: processes, compositions, and products
604 — Surgery
Phone:(571) 272-0043
Email:jacob.boeckelman@uspto.gov
Location:VA 22314
Title:Pat Examnr (Biolgy)
Service:6 years
Grade:GS-13

Grant Rate and Difficulty Ranking

91
3-Year Grant rate: 27% over 196 cases
Difficulty: Extremely Hard
Difficulty Percentile: 91st

With Examiner Boeckelman, you have a 27% chance of getting an issued patent by 3 years after the first office action. Examiner Boeckelman is an extremely hard examiner and in the 91st percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Boeckelman, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1655

Examiner Boeckelman's grant rate is lower than that of Art Unit 1655 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Boeckelman 2.2
Art Unit 1655 1.1

Interview Benefit

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Recent Dispositions

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeal History

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...